Skip to main content

#158406

Anti-Nab3p [2F12]

Cat. #158406

Anti-Nab3p [2F12]

Cat. #: 158406

Unit size: 100 ug

Availability: 10-12 weeks

Target: Nuclear polyadenylated RNA-binding protein 3

Class: Monoclonal

Application: WB ; IP

Reactivity: Yeast

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Institute: University of Florida

Tool Details
Target Details
Applications
Handling
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Nab3p [2F12]
  • Alternate name: Nab3p, NAB3
  • Research fields: Genetics
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Yeast
  • Host: Mouse
  • Application: WB ; IP
  • Description: Nab3p is an RNA binding-protein that required for termination of non-poly(A) transcripts and efficient splicing. It is part of the Nrd1 complex which interactions with exosome to mediate the 3' end formation of some mRNAs.
  • Immunogen: Recombinant fusion protein of Nab3p
  • Isotype: IgG1

Target Details

  • Target: Nuclear polyadenylated RNA-binding protein 3
  • Target background: Nab3p is an RNA binding-protein that required for termination of non-poly(A) transcripts and efficient splicing. It is part of the Nrd1 complex which interactions with exosome to mediate the 3' end formation of some mRNAs.

Applications

  • Application: WB ; IP

Handling

  • Format: Liquid
  • Unit size: 100 ug
  • Shipping conditions: Dry ice

References

  • Wilson et al. 1994. J Cell Biol. 127(5):1173-84. PMID: 7962083.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.